Trials / Completed
CompletedNCT02242565
Safety and Effectiveness of Different ShangRing Device Sizes for Adult Male Circumcision in Lusaka, Zambia
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 500 (actual)
- Sponsor
- FHI 360 · Academic / Other
- Sex
- Male
- Age
- 18 Years – 49 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study was to assess the safety, effectiveness and acceptability of providing a reduced number of ShangRing sizes for adult voluntary medical male circumcision (VMMC) within routine service delivery in Lusaka, Zambia.
Detailed description
We conducted a randomized controlled trial and enrolled 500 HIV-negative men aged 18-49 years at 3 clinics. Participants were randomized to 1 of 2 study arms (Standard Sizing arm vs Modified Sizing arm) in a 1:1 ratio. All 14 adult ShangRing sizes (40-26 mm inner diameter, each varying by 1 mm) were available in the Standard Sizing arm; the Modified Sizing arm used every other size (40, 38, 36, 34, 32, 30, 28 mm inner diameter). Each participant was scheduled for 2 follow-up visits: the removal visit (day 7 after placement) and the healing check visit (day 42 after placement), when they were evaluated for adverse events (AEs), pain, and healing.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | ShangRing | ShangRing device for male circumcision |
Timeline
- Start date
- 2014-10-01
- Primary completion
- 2015-09-01
- Completion
- 2015-12-01
- First posted
- 2014-09-17
- Last updated
- 2017-10-02
Locations
2 sites across 1 country: Zambia
Source: ClinicalTrials.gov record NCT02242565. Inclusion in this directory is not an endorsement.